News

Cathy Tie slips on a white lab coat bearing her name and the logo of her startup: Origin Genomics. "Welcome!" she says as she leads an NPR reporter, photographer and videographer on an exclusive tour of Origin's labs located...

This is the 17th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. The series is organized by Osagie K. Obasogie in...

THE INSTAGRAM POST, precision-guided by sex and age, had zeroed in on its target. Yuchen Tu is a conser­vatory-trained viola...

This is the 16th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring...

By Michael Hiltzik, Los Angeles Times | 01.21.2012
What are the chances that the prestigious Institute of Medicine will get an objective and balanced view of California’s stem-cell...
By Denise Grady, New York Times | 01.20.2012

The scientists who altered a deadly flu virus to make it more contagious have agreed to suspend their research for...

By Denise Grady, New York Times | 01.20.2012

The scientists who altered a deadly flu virus to make it more contagious have agreed to suspend their research for...

By Bonnie Rochman, Time | 01.19.2012

That tired truism about wanting only a healthy baby and not caring about gender? Puh-leeze. Women want daughters, and men...

By Bonnie Rochman, Time | 01.19.2012

That tired truism about wanting only a healthy baby and not caring about gender? Puh-leeze. Women want daughters, and men...

By Associated Foreign Press, Mysinchew.com | 01.19.2012
South Korea's government drug agency cleared the way Thursday for commercial sales of what it called the world's first approved...
By Associated Foreign Press, Mysinchew.com | 01.19.2012
South Korea's government drug agency cleared the way Thursday for commercial sales of what it called the world's first approved...
By BBC, BBC News | 01.19.2012

It replaces defective genetic material in the egg in order to eliminate rare mitochondrial diseases.

After the consultation into "three-person...